Risks of halting GLP-1 drugs and links to weight cycling

I hate to admit it but I see the point. After sema and adding other things I had to pause for eight weeks because of planned operations that got delayed. I had taken short breaks before for procedures but this time hit my lowest point since starting. Hunger returned hard and I ate more than I had in years. Holidays and snacks around didn't help. I only gained about seven pounds yet it feels awful. I believed I had control with healthy eating walking and some lifting while allowing small treats but once junk started it was hard to stop. Restarted low and slow to avoid getting sick. Still think they help but now expect to stay on something indefinitely.

Appreciate the share. Other views are useful yet this writer does not convince me. He relies on his own story plus an older study already overtaken by newer broader work. Plenty of people regain after quitting that much is clear and it must be tough. Still he presents that outcome as typical when the evidence does not support that view.

Was the author really unaware of muscle-loss issues before the article date? He also seems not to grasp that companies treat these as ongoing prescriptions rather than one-time fixes. The piece does raise fair points though. At full retail cost it can feel like having to keep paying just to hold steady. Muscle-loss findings differ across studies and formulations. Those who treat these as primary weight-loss tools without tackling food-addiction roots or other health factors may be missing part of the picture.

Main lesson for me is that brand prices do not work for long-term use by most people. Other sources are the practical route. I may stay on indefinitely and that is fine.

Quitting exercise loses the gains from exercise. Dropping a nutrition approach risks sliding backward. Cutting sleep routines harms rest. These medications and whatever follows are strong tools but articles often set up a false all-or-nothing claim to attack. Until something better appears I will keep using one weekly. If an oral version of the next triple agonist becomes available that is convenient for maintenance that could work too.

Lots of problems with the article but I always expected long-term use would be needed. These drugs address an underlying metabolic issue and none cure it. If I stopped I would expect the hunger weight and joint pain to return strongly. Even after nutrition counseling therapy and behavior shifts I doubt those steps fix the physiology itself.

I read that cholesterol medicines can lower the effectiveness of these drugs.

I meant the triple agonists improve triglycerides blood pressure blood sugar and A1C along with weight loss. Such medicines are usually continued unless something major changes. The new one could provide that change. Contraindications I saw relate more to slowed digestion affecting timing of oral medicines.

Even while benefiting I could not manage without a support program I have attended for sixteen years that reduced food noise and kept my weight stable for fourteen years before the drugs. Menopause and an autoimmune condition then slowed my metabolism. Most people with long-standing food-addiction patterns will struggle to keep weight off after stopping.

Not an expert but constructive criticism is worth hearing in a world full of echo chambers. Critical thinking has suffered because of them so reading opposing views is useful even when disagreeing.

The article only holds because users skip the required lifestyle steps such as lifting and hitting protein targets. Those two are essential whether using the drugs or not.

As a woman past menopause I needed bloodwork and hormone balance before weight loss could start. Added the medication after initial progress stalled. Thyroid adjustment later broke another stall. Everything has to align and these drugs are not a standalone fix. That has been my experience over four years.

I have always treated these as ongoing management not a cure. That is why I keep extra supply on hand. I have no plan to stop.

This is my second new year on an eighteen-month journey. Switched after a long stall on one brand then started the triple agonist in September. Three months in at seven milligrams I have lost fourteen pounds. Smaller doses did nothing for me. Now at a three-week stall after the latest increase and it is testing my outlook especially with fifty pounds still to go and PCOS plus metabolic and possible perimenopause factors involved.